Skip to product information
1 of 2

Chelsea Green Publishing

The LDN Book: Volume 2

Regular price $27.99 USD
Regular price Sale price $27.99 USD
Sale Sold out
Shipping calculated at checkout.
EMAIL ME WHEN IN STOCK

Shipping & Returns

*No Returns On Any Products - All Sales Are Final*

DOMESTIC ORDERS:

Orders are picked up daily from our office by USPS at 3:30 pm EST. To ensure that your order will get out the same day you place it, please make sure to have the order in by that time. All orders placed after 3:30 pm EST will get picked up by USPS the next day.

If you are local to the Cleveland, Ohio area, you should receive your order in 1-2 days. You can also pick up orders directly from our Clinic, located at 2460 Fairmount Boulevard, Suite #202, Cleveland Heights, OH 44106.

INTERNATIONAL ORDERS:

You are responsible for paying any customs or duties.

The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More!

A comprehensive examination of Low Dose Naltrexone—a little-known drug with big potential. A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination.

LDN, originally prescribed in higher doses as a treatment for opioid addiction, works by blocking opioid receptors, thereby stimulating the production of endorphins, mitigating the inflammatory process, and stabilizing the immune response. Prescribed off-label and administered in small daily doses, this generic drug has proven useful in treating many different ailments.

Expanding on the information presented in The LDN Book, Volume 1, which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue, Volume 2 highlights the latest clinical trials, case studies, and research with explanations from a dozen medical professionals on how they are using LDN to help patients suffering from:

  • Chronic pain

  • Parkinson’s disease

  • Dermatologic conditions

  • Traumatic brain injury 

  • Lyme disease and more

The LDN Book, Volume 2 is both a resource for practitioners, pharmacists, and patients, and a renewed call for further research on the healing potential of this generic drug.

Description

The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More!

A comprehensive examination of Low Dose Naltrexone—a little-known drug with big potential. A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination.

LDN, originally prescribed in higher doses as a treatment for opioid addiction, works by blocking opioid receptors, thereby stimulating the production of endorphins, mitigating the inflammatory process, and stabilizing the immune response. Prescribed off-label and administered in small daily doses, this generic drug has proven useful in treating many different ailments.

Expanding on the information presented in The LDN Book, Volume 1, which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue, Volume 2 highlights the latest clinical trials, case studies, and research with explanations from a dozen medical professionals on how they are using LDN to help patients suffering from:

  • Chronic pain

  • Parkinson’s disease

  • Dermatologic conditions

  • Traumatic brain injury 

  • Lyme disease and more

The LDN Book, Volume 2 is both a resource for practitioners, pharmacists, and patients, and a renewed call for further research on the healing potential of this generic drug.

These products have not been approved by or evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease.

SHOP OUR BEST SELLERS